Biostatistics Oncology TA Head
Amgen
Summary
In this vital role as Biostatistics Oncology TA Head, you will define enterprise-level strategy for the function. This role sets vision, represents Biostatistics for Oncology at the highest levels of the organization, and acts as the external face of the function to regulators, industry groups, and scientific forums. In this role you will be operating with significant autonomy, and drive innovation, talent development, and organizational transformation.
Job description
Responsibilities
- Sets and leads the biostatistical strategy and technical expertise for Oncology TA, including opportunities for innovation and continuous improvement
- Advises and collaborates with cross-functional TA Heads, including related analytical groups, across Amgen regarding statistical strategies that impact drug development and regulatory/HTA/medical strategies
- Identifies and implements new pragmatic methodologies aimed at improving drug development strategy, regulatory science, and patient centricity
- Provide statistical consultancy, training, and advice within Amgen
- Drive and contribute to the development of Amgen Policies, SOPs and other controlled biostatistics documents
- Implement and manage standards, technical quality, and consistent approaches in strategy, study design, and statistical analysis for designated TAs
- Influence Amgen’s statistical priorities internally and externally via KOL relationships, publications, presentations, and through key partnerships as appropriate
- Provide oversight for Key Design Elements (KDE), protocols, Statistical Analysis Plans (SAPs), Flash Memos/Summary of Report (SoR), Clinical Study Reports (CSRs), publications, and contribute to regulatory documents in various development stages, reimbursement documents and other communications for TAs
- Partners with functional leaders across Amgen and with external stakeholders
- Contributes to CfDA organizational strategy as part of leadership team; serves as a primary representative for Oncology TA at Amgen-wide committees and meetings
- Engages and aligns staff with Amgen priorities, including identifying and championing impactful and innovative opportunities for Oncology TA
- Leads decisions regarding statistical differences of opinion (e.g., statistical methodologies) within Oncology TA
- Manages technical and good practice oversight within Oncology TA
- Provide statistical strategy on signal detection capabilities for use in the analysis of pre-marketing and post-marketing adverse event databases, and on life-cycle safety-related activities for a product
Basic Qualifications
- Doctorate degree & 6 years of biostats oncology experience OR Master’s degree & 10 years of biostats oncology experience OR Bachelor’s degree & 12 years of biostats oncology experience
- AND 6 years of managerial experience directly managing people and/or leadership experience leading teams, projects, programs or directing the allocation of resources
Preferred Qualifications
- Experience developing policies and SOPs
- International collaboration and experience working globally
- Scientific research / publications in one or more areas of statistical science
- Experience working effectively in a globally dispersed team environment with cross-cultural partners
- Life Cycle Drug Development Experience (e.g. global product lead statistician experiences)
- Excellent oral and written English communication skills
- Thorough understanding of regulatory and industry trends in standards and their implementation
- Established records of strong leadership and people management skills
- Prior regulatory and reimbursement submission experience, including advisory committees
- Doctorate in Statistics/Biostatistics or related subject with high statistical content and at least 12 years of post-graduate statistical experience in the pharmaceutical industry or medical research including related Oncology TA experience
- Or Master’s degree in Statistics/Biostatistics or related subject with high statistical content and at least 16 years of post-graduate statistical experience in the pharmaceutical industry or medical research including related Oncology TA experience
Requirements
- Doctorate degree & 6 years of biostats oncology experience OR Master’s degree & 10 years of biostats oncology experience OR Bachelor’s degree & 12 years of biostats oncology experience
- 6 years of managerial experience directly managing people and/or leadership experience leading teams, projects, programs or directing the allocation of resources
- Experience developing policies and SOPs
- International collaboration and experience working globally
- Scientific research / publications in one or more areas of statistical science
- Experience working effectively in a globally dispersed team environment with cross-cultural partners
- Life Cycle Drug Development Experience (e.g. global product lead statistician experiences)
- Excellent oral and written English communication skills
- Thorough understanding of regulatory and industry trends in standards and their implementation
- Established records of strong leadership and people management skills
- Prior regulatory and reimbursement submission experience, including advisory committees
- Doctorate in Statistics/Biostatistics or related subject with high statistical content and at least 12 years of post-graduate statistical experience in the pharmaceutical industry or medical research including related Oncology TA experience
- Or Master’s degree in Statistics/Biostatistics or related subject with high statistical content and at least 16 years of post-graduate statistical experience in the pharmaceutical industry or medical research including related Oncology TA experience
Benefits
- Retirement and Savings Plan
- Group medical coverage
- Dental coverage
- Vision coverage
- Life insurance
- Disability insurance
- Flexible spending accounts
- Discretionary annual bonus
- Stock-based long-term incentives
- Paid time-off plans
- Flexible work models
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.